Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
Launched by M.D. ANDERSON CANCER CENTER · Apr 24, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand the experiences and needs of men who have had surgery to remove lymph nodes in the groin area due to penile cancer. Researchers want to learn how patients feel during and after these procedures to improve care and support for future patients. If you are a man aged 65 to 74 who has been diagnosed with penile cancer and had surgery involving inguinal lymph nodes at least six months ago, you may be eligible to participate in this study.
Participants will be asked to take part in a 60-minute telephone interview where they can share their thoughts and experiences related to their surgery. This is a great opportunity to help improve the treatment and care for others facing similar challenges. Please note that individuals under 18 years old, those who have not had the specific surgeries being studied, and non-English speakers will not be eligible for this trial. Your insights can make a difference!
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • --Patients diagnosed with penile cancer who have undergone invasive inguinal node procedures (ILND and/or DSNB) and are at least 6 months post-procedure
- Exclusion Criteria:
- • Patient's ≤18 years of age
- • Patients who have not undergone invasive surgical procedures involving the inguinal lymph nodes
- • Non-English-speaking patients For interviews: people who are physically and/or cognitively incapable of participating in a 60minute telephone interview as determined by a clinical provider or the patient.
About M.D. Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Curtis Pettaway, BS, MD
Principal Investigator
MD Anderson
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported